sst support burn l carnitine Ice Berry though results will vary based on individual commitment to exercise and diet. How do PERFORMIX® SST Support

Stacking too many interventions at once makes it impossible to know what is working Physician oversight is important

Yang S, Alnaqeeb M, Simpson H, Goldspink G

discontinued CJC-1295 (DAC) Not FDA-approved Feature Phase III Trial Data Tesamorelin Yes (n=816 pooled) Sermorelin No adult Phase III VAT datasets CJC-1295 (DAC) No Feature Visceral Fat Reduction Tesamorelin 15-20% at 26 weeks Sermorelin Not formally studied in RCTs CJC-1295 (DAC) Not formally studied in RCTs Feature Liver Fat Reduction Tesamorelin 32% at 12 months (NAFLD trial) Sermorelin Not studied CJC-1295 (DAC) Not studied Feature Typical Research Dose Tesamorelin 2 mg daily Sermorelin 200-300 mcg nightly CJC-1295 (DAC) 1-2 mg weekly Feature Unique Advantage Tesamorelin Only FDA-approved GHRH with deepest trial evidence Sermorelin Longest historical track record CJC-1295 (DAC) Weekly dosing convenience Tesamorelin is the only GHRH peptide with active FDA approval and validated Phase III visceral-fat data

Chargers with storage functions help maintain optimal voltage during storage, stabilizing battery chemistry and reducing degradation

D.Huerta-HuertaA.Balleza-AlejandriL

doi: 10.1038/nrc3495 16